Physician Failed to Monitor and Document Diabetes Management
Summary
The facility failed to ensure the physician provided comprehensive care for a resident with type 2 diabetes mellitus, acute kidney failure, CKD stage III, vascular dementia, and cognitive communication deficit. The resident was admitted after a hospital stay in which blood sugars ranged from 100 to 294 mg/dL, urine glucose was 3+, and treatment included insulin glargine, insulin lispro sliding scale, and Accu-Chek monitoring four times daily. The hospital discharge summary indicated the resident’s home medications were resumed on discharge, but there was no hemoglobin A1C in the hospital records. The resident’s care plan identified risk for hypoglycemia and hyperglycemia and included interventions for diabetes medications, glucose monitoring, education, fasting serum blood sugars, and monitoring for signs of abnormal blood sugar. However, the physician’s notes over the following months repeatedly documented the resident as diabetic with good control, listed Glyburide and Metformin as medications, and used an outdated weight from 2014. Those notes did not include an assessment or plan for diabetes monitoring. The physician’s orders also showed no blood sugar checks or anti-diabetic medications from admission through late March. Laboratory testing later showed severe hyperglycemia, with blood glucose values of 425 mg/dL and 447 mg/dL and hemoglobin A1C values of 16.7% and 17.0%, with mean blood glucose values of 433 mg/dL and 441 mg/dL. After the A1C resulted at 17%, the physician was notified and new orders were written for insulin glargine and Farxiga. During interview, the physician stated blood sugar checks should have been established on admission, then later stated he assumed diabetes was well controlled if the hospital sent no insulin or blood sugar orders and admitted he did not review the hospital documentation on admission beyond the discharge summary and discharge orders. The facility’s diabetes policy stated glucose monitoring frequency should be ordered by the physician and that A1C reflects average blood glucose over two to three months; ADA information also identified A1C of 17% as an estimated average glucose of 441 mg/dL and noted that high A1C indicates frequent high blood glucose.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.